PRODUCT LITERATURE
Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients
The objective of the study is to evaluate the efficacy and safety of oral inosine pranobex as compared with acyclovir in the treatment of recurrent herpes labialis (RHL) and recurrent herpes genitalis (RHG). A multicenter
double-blind, double-dummy, randomized, controlled, parallel group trial was conducted in 144 patients with RHL
and 144 RHG.
No other version available